The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

Screening possible immune functions related to anticancer treatmentCommon immune checkpoints were browsed and screened for possible immunotherapeutic value, and the representative immune checkpoint molecules13,14,15 ADORA2A, BTLA, Nectin-2 (CD112), CD160, CD244, PD-L1, CD96, CSF1R, CTLA4, HAVCR2, IDO1, IL10, IL10RB, KDR, KIR2DL1, KIR2DL3, LAG3, LGALS9, PDCD1, PDCD1LG2, PVRL2, TGFB1, TGFBR1, TIGIT, VTCN1, TNF Receptor Superfamily Member 14 [...]

Published September 20, 2021 at 02:42PM. Read full article at Stem Cells in the News Portal.